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age children with allergic diseasesFig. 1. No differences in the serum levels of periostin were seen between the children
with and without allergic diseases. The serum levels of periostin in the children with
allergic diseases were not signiﬁcantly different from those without allergic diseases.
The serum levels of periostin in the children were signiﬁcantly higher than those
observed in the healthy adults, regardless of the presence or absence of allergic dis-Dear Editor
Periostin is a secreted extracellular matrix protein that has
been shown to play an important role in the pathogenesis of
allergic diseases, including both Th2 inﬂammation and tissue
remodeling.1,2 Originally, the periostin gene was reported to be a
“Th2 signature” gene that is upregulated in IL-13-stimulated bron-
chial epithelial cells.3,4 In addition to blood eosinophilia and the
exhaled nitric oxide level, the serum periostin level is thought to
be a good biomarker of airway eosinophilic inﬂammation and
airway remodeling in adult asthmatics5,6 and may be useful for
predicting the effects of therapies targeting mediators of Th2
inﬂammation, such as anti-IL-13 antibodies7 or anti-IgE anti-
bodies,8 in patients with bronchial asthma. The serum periostin
levels are also increased in adult patients with atopic dermatitis9
and are believed to reﬂect the status of chronic skin inﬂammation.
Taken together, the serum periostin level is a promising biomarker
of allergic diseases in adults. However, little is known about the
usefulness of this parameter as a biomarker for allergic diseases
in childhood.
We recruited 304 elementary school-age children from an
elementary school attached to Chiba University. The study proto-
col was approved by the Committee on Human Research of Chiba
University. Informed consent was obtained from each of the
study subjects and their guardians. The diagnosis of current
bronchial asthma was made according to the ISSAC (International
Study of Asthma and Allergies in Childhood) questionnaire. Con-
current physician-diagnosed atopic dermatitis, allergic rhinitis
and food allergies were assessed. Of the 156 children with any
type of allergic disease, 27.6% had multiple allergic diseases. Chil-
dren without any allergic diseases and those not exhibiting
serum speciﬁc IgE to house dust mites, cedar pollen or egg
whites were deﬁned as “healthy children.” We recruited 204
adult volunteers without any allergic diseases as healthy adults.
The characteristics of the subjects are shown in Supplementary
Table 1.
The serum periostin levels were measured using a sandwich
enzyme-linked immunosorbent assay, as previously described.6
Differences in the serum periostin levels between the study groups
were determined using the KruskaleWallis test followed by Dunn's
multiple comparisons test. The relationships between the serum
levels of periostin and the age, IgE or eosinophil counts were
assessed by an analysis of variance and Spearman's rank
correlation.Peer review under responsibility of Japanese Society of Allergology.
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licenses/by-nc-nd/4.0/).Unexpectedly, we did not detect any increase in the serum peri-
ostin level in children with allergic diseases in comparison to
healthy children (Fig. 1). In addition, compared to that observed
in the healthy adult controls, the serum periostin levels were signif-
icantly higher in the elementary school-age children, regardless of
the presence or absence of allergic diseases (Fig. 1). To clarify
whether our non-signiﬁcant results were due to a lack of statistical
power, we conducted post hoc power analyses using the G*Power
3.110 software program. The post hoc power of ANOVA (calculated
effect size 0.80, a error 0.05, total sample size 84, number of groups
6) was 1.00, thus suggesting that our negative ﬁnding may not be
attributed to the fact that we utilized a limited sample size. We
did not detect any correlations between the serum periostin level
and the blood eosinophil count or serum total IgE level, suggesting
that the serum level of periostin is not associated with an atopic
status in elementary school-age children (Supplementary Fig. 1).
To clarify the normal ranges of serum periostin at different ages,
we plotted the serum levels of periostin for both healthy children
and healthy adults. The serum levels of periostin appeared to
slightly increase in an age-dependent manner in childhood,
although the correlation coefﬁcient was low (r 0.35, p < 0.05)
(Fig. 2A). On the other hand, the serum levels of periostin in adult-
hood appeared to be lower than those in childhood, and to slightly
decrease during adulthood (r 0.17, p < 0.05) (Fig. 2B). As periostin iseases (***p < 0.001, compared to each group of children). Abbreviations: HA, Healthy
adults; HC, Healthy children; BA, Bronchial asthma; AD, Atopic dermatitis; AR, Allergic
rhinitis; FA, Food allergies; n. s., not signiﬁcant.
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Fig. 2. The serum periostin levels in the subjects without allergic diseases. A) The serum periostin levels in the elementary school-age children without allergic diseases. Bottom of
the box, 25th percentile; Line in the middle of box, median; Top of the box, 75th percentile; Whiskers, to the smallest value and to the largest value. B) The serum periostin levels in
the subjects without allergic diseases in both elementary school-age children and adults.
Letter to the Editor / Allergology International 64 (2015) 289e290290produced by osteocytes and periosteal osteoblasts,11 the serum
level of periostin may thus be largely inﬂuenced by the rate of
bone metabolism in childhood.11 Therefore, the high baseline level
of serum periostin may mask any increase in the serum periostin
level due to allergic diseases in childhood.
In conclusion, no increase in the serum periostin level was
detected in elementary school-age children with allergic diseases,
likely due to the high rate of bone turnover in this group. Further
studies are needed to clarify the normal ranges of serum periostin
at other ages (infancy and adolescence) and for which age groups
the serum periostin level is a useful biomarker.
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